JSPR
Jasper Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.71
+3.23%2
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+38.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 4, 2026 | Crutcher Patrick J · director | A-Award | 7,500 | $0.63 |
| Aug 4, 2026 | WIGGANS THOMAS G · director | A-Award | 7,500 | $0.63 |
| Aug 4, 2026 | Shizuru Judith Anne · director | A-Award | 7,500 | $0.63 |
| Aug 4, 2026 | EMSTER KURT VON · director | A-Award | 7,500 | $0.63 |
| Aug 4, 2026 | Lucas Svetlana · director | A-Award | 7,500 | $0.63 |
| Jul 22, 2026 | Ros Matthew E · officer: Chief Operating Officer | Purchase | 881 | $0.00 |
| Jul 20, 2026 | Crutcher Patrick J · director | Purchase | 888 | $0.00 |
| Jul 20, 2026 | Crutcher Patrick J · director | A-Award | 15,000 | $0.77 |
| Feb 10, 2026 | Mahal Jeetinder Singh · director, officer: CEO and President | A-Award | 500,000 | $1.35 |
| Jan 5, 2026 | Mahal Jeetinder Singh · officer: Chief Operating Officer | A-Award | 90,000 | $1.84 |
| Jan 5, 2026 | CROSS HERB · officer: Chief Financial Officer | A-Award | 90,000 | $1.84 |
| Jan 5, 2026 | MARTELL RON · director, officer: President, CEO and Director | A-Award | 234,000 | $1.84 |
| Sep 24, 2025 | Shizuru Judith Anne · director | Purchase | 41,000 | $2.43 |
| Sep 24, 2025 | WIGGANS THOMAS G · director | Purchase | 41,000 | $2.43 |
| Sep 24, 2025 | Lucas Svetlana · director | Purchase | 20,000 | $2.43 |
| Sep 24, 2025 | MARTELL RON · director, officer: President and CEO | Purchase | 41,000 | $2.43 |
| Jul 3, 2025 | Nolet Chris · director | A-Award | 7,500 | $6.77 |
| Jul 3, 2025 | Kapoor Vishal · director | A-Award | 7,500 | $6.77 |
| Jul 3, 2025 | WIGGANS THOMAS G · director | A-Award | 7,500 | $6.77 |
| Jul 3, 2025 | Lucas Svetlana · director | A-Award | 7,500 | $6.77 |
| Jul 3, 2025 | EMSTER KURT VON · director | A-Award | 7,500 | $6.77 |
| Jul 3, 2025 | Brun Scott C. · director | A-Award | 7,500 | $6.77 |
| Jul 3, 2025 | Shizuru Judith Anne · director | A-Award | 7,500 | $6.77 |
| Jun 6, 2025 | Mahal Jeetinder Singh · officer: Chief Operating Officer | A-Award | 90,000 | $6.00 |
| Jun 6, 2025 | CROSS HERB · officer: Chief Financial Officer | A-Award | 90,000 | $6.00 |
| Jun 6, 2025 | Tucker Edwin Jonathan · officer: Chief Medical Officer | A-Award | 90,000 | $6.00 |
| Jun 6, 2025 | MARTELL RON · director, officer: President and CEO | A-Award | 234,000 | $6.00 |
| Feb 18, 2025 | MARTELL RON · director, officer: President, CEO and Director | A-Award | 130,000 | $6.20 |
| Feb 18, 2025 | CROSS HERB · officer: Chief Financial Officer | A-Award | 50,000 | $6.20 |
| Feb 18, 2025 | Tucker Edwin Jonathan · officer: Chief Medical Officer | A-Award | 50,000 | $6.20 |
Institutional positioning
13F filings over the trailing two quarters
New 13Increased 18Reduced 14Sold out 59
| Filer | Action | Shares | Filed |
|---|---|---|---|
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | Unchanged | 2,668,395 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 1,746,492 | Mar 25, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 1,617,531 | May 15, 2026 |
| ACORN CAPITAL ADVISORS, LLC | Reduced | 1,411,492 | May 15, 2026 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | New Position | 1,352,106 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 1,333,420 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,172,597 | May 15, 2026 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | Unchanged | 1,100,726 | May 15, 2026 |
| CARLYLE GROUP INC. | Unchanged | 1,066,189 | May 8, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | Reduced | 582,751 | May 15, 2026 |
| LION POINT CAPITAL, LP | Unchanged | 465,000 | May 15, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | Increased | 322,273 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 317,677 | May 15, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 293,259 | May 18, 2026 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | Increased | 276,312 | May 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 4, 2026